Assignee
STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD
CN·7 granted patents·11 pending applications·2 citations·filing 2016–2023
Top patents by PatentIndex Score
18 records- 0177US11883464B2Nerve growth factor fusion protein, preparation method and use thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Jan 30, 2024·1 cites·9 claims
- 0277US2024226236A9Nerve growth factor fusion protein, preparation method and use thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0374US11213568B2Nerve growth factor mutantSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Jan 4, 2022·1 cites·9 claims
- 0474US2023241169A1Nerve growth factor mutantSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0570US2022088136A1Nerve growth factor mutantSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0663US2025326828A1Antibodies Specifically Recognizing Gdf15 and Uses ThereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0760US2024343817A1Antibody that specifically recognizes cd40 and application thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0859US2025277022A1Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0958US2024400629A1Long-acting nerve growth factor polypeptides and uses thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1056US2022088139A1Nerve growth factor mutantSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1153US2023220057A1Antibodies specifically recognizing nerve growth factor and uses thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1248US12460008B2Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Nov 4, 2025·0 cites·15 claims
- 1346US12448434B2Antibodies specifically recognizing Pseudomonas PcrV and uses thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 21, 2025·0 cites·12 claims
- 1445US12534521B2Antibodies specifically recognizing C5A and uses thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Jan 27, 2026·0 cites·11 claims
- 1545US2021108197A1Shrna expression cassette, polynucleotide sequence carrying same, and application thereofSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
- 1629US2018110833A1Nerve growth factor composition and powder injectionSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2016·Application pending·0 cites
- 1727US10576129B2Nerve growth factor composition and powder injectionSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Mar 3, 2020·0 cites·18 claims
- 1826US11077193B2Nerve growth factor composition and powder injectionSTAIDSON BEIJING BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Aug 3, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →